LNPEP and neurodegenerative disease: Moreover, accumulating evidence demonstrates that the pharmacological inhibition of IRAP may hold promise as a valuable approach not only for the treatment of memory disorders and neurodegenerative diseases but also potentially for neuroprotection in connection with ischemic stroke and other cardiovascular disorders.